Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Correlation Analysis of Ki67 Expression and EGFR Mutation on the Risk of Recurrence and Metastasis in Postoperative Patients with Stage I Lung Adenocarcinoma].

Zhongguo fei ai za zhi = Chinese journal of lung cancer - 20 Dec 2022

Xu Lili, Guo Renhua

Abstract excerpt

BACKGROUND: The prognosis of stage I non-small cell lung cancer (NSCLC) is generally good. However, some of the stage I NSCLC patients still may have early recurrence and metastasis, and there is no standard method to screen this part of the population. The aim of this study is to investigate the relationship between Ki67 expression as well as epidermal growth factor receptor (EGFR) mutation and the risk of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to Ki-67 Antigen

Share to Lung Neoplasms

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 36617471
DOI: 10.3779/j.issn.1009-3419.2022.101.55
PMCID: PMC9845089

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Correlation Analysis of Ki67 Expression and EGFR Mutation on the Risk of Recurrence and Metastasis in Postoperative Patients with Stage I Lung Adenocarcinoma].PMID 36617471Read ↗

Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas.Semantic proximity Read ↗

[Predictive role of EGFR mutation status on postoperative prognosis in patients with resected lung adenocarcinomas].Semantic proximity Read ↗

EGFR Mutation Impacts Recurrence in High-Risk Early-Stage Lung Adenocarcinoma in the IASLC Grading SystemSemantic proximity Read ↗

[Effectiveness of tyrosine kinase inhibitors against non-small cell lung cancer patients with postoperative recurrence harboring uncommon EGFR mutations].Semantic proximity Read ↗

Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.Semantic proximity Read ↗

A Retrospective Study of Stage I to IIIa Lung Adenocarcinoma After Resection: What Is the Optimal Adjuvant Modality for Patients With an EGFR Mutation?Semantic proximity Read ↗

[Epithelial growth factor receptor mutation status to the effective of survival in non-small cell lung cancer after surgery].Semantic proximity Read ↗

[Value of immunohistochemical staining with mutation-specific antibodies in detecting EGFR mutations: a meta-analysis].Semantic proximity Read ↗

Mutations of the EGFR and K-ras genes in resected stage I lung adenocarcinoma and their clinical significance.Semantic proximity Read ↗

Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.Semantic proximity Read ↗

Biological difference between L858R and exon 19 deletion contributes to recurrence-free survival of resected non-small cell lung cancerSemantic proximity Read ↗

Prognostic value of EGFR mutations in surgically resected pathological stage I lung adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.